Amplia Therapeutics Limited (ATX.AX)

AUD 0.08

(-2.35%)

EBITDA Summary of Amplia Therapeutics Limited

  • Amplia Therapeutics Limited's latest annual EBITDA in 2024 was -4.55 Million AUD , up 37.23% from previous year.
  • Amplia Therapeutics Limited's latest quarterly EBITDA in 2024 FY was N/A , down -20.73% from previous quarter.
  • Amplia Therapeutics Limited reported an annual EBITDA of -7.26 Million AUD in 2023, down -31.62% from previous year.
  • Amplia Therapeutics Limited reported an annual EBITDA of -3.64 Million AUD in 2022, down -45.15% from previous year.
  • Amplia Therapeutics Limited reported a quarterly EBITDA of -3.56 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Amplia Therapeutics Limited reported a quarterly EBITDA of -3.44 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Amplia Therapeutics Limited (2024 - 2013)

Historical Annual EBITDA of Amplia Therapeutics Limited (2024 - 2013)

Year EBITDA EBITDA Growth
2024 -4.55 Million AUD 37.23%
2023 -7.26 Million AUD -31.62%
2022 -3.64 Million AUD -45.15%
2021 -2.33 Million AUD -71.56%
2020 -2.22 Million AUD -17.33%
2019 -1.88 Million AUD 59.95%
2018 -4.3 Million AUD 46.2%
2017 -7.1 Million AUD -32.47%
2016 -4.44 Million AUD -73.74%
2015 -3.68 Million AUD -53.58%
2014 -2.61 Million AUD -48.54%
2013 -1.48 Million AUD 0.0%

Peer EBITDA Comparison of Amplia Therapeutics Limited

Name EBITDA EBITDA Difference
EZZ Life Science Holdings Limited 10.37 Million AUD 143.946%
Anatara Lifesciences Ltd -1.45 Million AUD -213.016%
Zelira Therapeutics Limited -36.44 Million AUD 87.488%
Biome Australia Limited -1.57 Million AUD -188.902%
Patrys Limited -3.49 Million AUD -30.567%
Orthocell Limited -11.68 Million AUD 60.966%
Imugene Limited -147.97 Million AUD 96.919%
Noxopharm Limited -5.94 Million AUD 23.31%
PYC Therapeutics Limited -38.11 Million AUD 88.038%
Chimeric Therapeutics Limited -11.29 Million AUD 59.649%
Prescient Therapeutics Limited -7.18 Million AUD 36.546%
Proteomics International Laboratories Limited -7.88 Million AUD 42.191%
Cynata Therapeutics Limited -9.95 Million AUD 54.176%
CSL Limited 4.73 Billion AUD 100.096%
Arovella Therapeutics Limited -8.83 Million AUD 48.381%
Bio-Gene Technology Limited -2.97 Million AUD -53.264%
Clinuvel Pharmaceuticals Limited 51.86 Million AUD 108.792%
Starpharma Holdings Limited -12.57 Million AUD 63.747%
Nanollose Limited -1.14 Million AUD -297.212%
Memphasys Limited -3.3 Million AUD -37.847%
Invex Therapeutics Ltd -720.44 Thousand AUD -532.89%
NeuroScientific Biopharmaceuticals Limited -1.79 Million AUD -153.835%
Botanix Pharmaceuticals Limited -13.91 Million AUD 67.243%
Island Pharmaceuticals Limited -2.81 Million AUD -61.796%
Race Oncology Limited -14.2 Million AUD 67.898%
Nyrada Inc. -4.59 Million AUD 0.796%
Telix Pharmaceuticals Limited 22.96 Million AUD 119.854%
Dimerix Limited -24.95 Million AUD 81.731%
PharmAust Limited -9.45 Million AUD 51.759%
Immutep Limited -42.87 Million AUD 89.365%
Clarity Pharmaceuticals Ltd -44.64 Million AUD 89.788%
Alterity Therapeutics Limited -19.57 Million AUD 76.703%
BTC Health Limited 1.05 Million AUD 532.072%
Acrux Limited -7.93 Million AUD 42.509%
Neuren Pharmaceuticals Limited 199.26 Million AUD 102.288%
Biotron Limited -5.04 Million AUD 9.533%
Tissue Repair Ltd -5.77 Million AUD 21.046%
AdAlta Limited -5.3 Million AUD 14.014%
Radiopharm Theranostics Limited -45.37 Million AUD 89.952%
Hexima Limited -995.54 Thousand AUD -358.001%
AnteoTech Limited -11.57 Million AUD 60.595%
Paradigm Biopharmaceuticals Limited -64.53 Million AUD 92.935%
Recce Pharmaceuticals Ltd -21.35 Million AUD 78.648%
Avecho Biotechnology Limited -3.24 Million AUD -40.619%
Actinogen Medical Limited -12.92 Million AUD 64.712%
Immuron Limited -6.19 Million AUD 26.367%
Argenica Therapeutics Limited -1.89 Million AUD -140.283%